Mutant IDH1 promotes phagocytic function of microglia/macrophages in gliomas by downregulating ICAM1

2021 ◽  
Author(s):  
Ding Ma ◽  
Daqian Zhan ◽  
Yi Fu ◽  
Shuang Wei ◽  
Bachchu Lal ◽  
...  
Diabetes ◽  
1982 ◽  
Vol 31 (1) ◽  
pp. 7-11 ◽  
Author(s):  
M. Iavicoli ◽  
U. Di Mario ◽  
P. Pozzilli ◽  
J. Canalese ◽  
L. Ventriglia ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Adriana Valeria Jäger ◽  
Paula Arias ◽  
Maria Virginia Tribulatti ◽  
Marcela Adriana Brocco ◽  
Maria Victoria Pepe ◽  
...  

AbstractPathogens phagocytosis and the uptake of apoptotic cells (efferocytosis) are essential macrophages tasks, classically considered as mutually exclusive. Macrophages have been observed to polarize into either pro-inflammatory/microbicidal or anti-inflammatory/efferocytic phenotypes. However, macrophage functions have shown to be more complex. Furthermore, little is known about the regulation of efferocytosis under inflammatory conditions. In this study, we elucidate the modulation of the macrophage efferocytic function during an inflammatory stimulus. We find that bone marrow-derived macrophages (BMDM) are very efficient in engulfing both the bacterial pathogen Pseudomonas aeruginosa and apoptotic cells. BMDM showed a high bactericidal capacity unaffected by the concomitant presence of apoptotic material. Plasticity in macrophage programming, in response to changing environmental cues, may modulate efferocytic capability. In this work, we further show that, after phagocyting and processing Pseudomonas aeruginosa, macrophages highly increase their efferocytic capacity without affecting their phagocytic function. Moreover, we demonstrate that Pseudomonas aeruginosa enhances efferocytosis of these phagocytes through the IL-6 signaling pathway. Our results show that the inflammatory response generated by the bacterial processing enhances these macrophages’ capacity to control inflammation through an increased efferocytosis.


Biomolecules ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 740
Author(s):  
Joi Weeks ◽  
Alexandra I. Strom ◽  
Vinnie Widjaja ◽  
Sati Alexander ◽  
Dahra K. Pucher ◽  
...  

Isocitrate dehydrogenase (IDH1) catalyzes the reversible NADP+-dependent oxidation of isocitrate to α-ketoglutarate (αKG). IDH1 mutations, primarily R132H, drive > 80% of low-grade gliomas and secondary glioblastomas and facilitate the NADPH-dependent reduction of αKG to the oncometabolite D-2-hydroxyglutarate (D2HG). While the biochemical features of human WT and mutant IDH1 catalysis have been well-established, considerably less is known about mechanisms of regulation. Proteomics studies have identified lysine acetylation in WT IDH1, indicating post-translational regulation. Here, we generated lysine to glutamine acetylation mimic mutants in IDH1 to evaluate the effects on activity. We show that mimicking lysine acetylation decreased the catalytic efficiency of WT IDH1, with less severe catalytic consequences for R132H IDH1.


2010 ◽  
Vol 70 (22) ◽  
pp. 8981-8987 ◽  
Author(s):  
Meghan J. Seltzer ◽  
Bryson D. Bennett ◽  
Avadhut D. Joshi ◽  
Ping Gao ◽  
Ajit G. Thomas ◽  
...  
Keyword(s):  

2003 ◽  
Vol 145 (2) ◽  
pp. 159-163 ◽  
Author(s):  
Saraswathi Panneerselvam ◽  
Swaminathan Govindasamy

1994 ◽  
Vol 81 (SUPPLEMENT) ◽  
pp. A245 ◽  
Author(s):  
N. Kotani ◽  
H. Hashimoto ◽  
J. S. Wang ◽  
C. Y. Lin ◽  
M. F. Roizen

Sign in / Sign up

Export Citation Format

Share Document